Dielectrophoretic trapping of single leukemic cells using the conventional and compact optical measurement systems
暂无分享,去创建一个
Paul C H Li | Hamideh Sharifi Noghabi | Mandy Soo | Avid Khamenehfar | H. Sharifi Noghabi | A. Khamenehfar | Mandy Soo | P. C. Li
[1] A. Duncan,et al. Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line. , 1992, Science.
[2] Paul C H Li,et al. Real-time detection of the early event of cytotoxicity of herbal ingredients on single leukemia cells studied in a microfluidic biochip. , 2009, Integrative biology : quantitative biosciences from nano to macro.
[3] U. Germann,et al. P-glycoprotein--a mediator of multidrug resistance in tumour cells. , 1996, European journal of cancer.
[4] Dawei Xu,et al. Different effects of metabolic inhibitors and cyclosporin A on daunorubicin transport in leukemia cells from patients with AML. , 2003, Leukemia research.
[5] Kun Li,et al. TanshinoneIIA enhances the chemosensitivity of breast cancer cells to doxorubicin through down-regulating the expression of MDR-related ABC transporters. , 2017, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[6] P. J. Russell,et al. Label-free isolation of a prostate cancer cell among blood cells and the single-cell measurement of drug accumulation using an integrated microfluidic chip. , 2015, Biomicrofluidics.
[7] H. Landau,et al. The farnesyl transferase inhibitor, tipifarnib, is a potent inhibitor of the MDR1 gene product, P-glycoprotein, and demonstrates significant cytotoxic synergism against human leukemia cell lines , 2007, Leukemia.
[8] T. Tsuruo,et al. Clinical significance of multidrug resistance P-glycoprotein expression on acute nonlymphoblastic leukemia cells at diagnosis. , 1992, Blood.
[9] T. Ozben. Mechanisms and strategies to overcome multiple drug resistance in cancer , 2006, FEBS letters.
[10] I. Pastan,et al. Most drugs that reverse multidrug resistance also inhibit photoaffinity labeling of P-glycoprotein by a vinblastine analog. , 1988, Molecular pharmacology.
[11] A. Yu,et al. ABC transporters in multidrug resistance and pharmacokinetics, and strategies for drug development. , 2014, Current pharmaceutical design.
[12] Zhe-Sheng Chen,et al. Dacomitinib antagonizes multidrug resistance (MDR) in cancer cells by inhibiting the efflux activity of ABCB1 and ABCG2 transporters. , 2018, Cancer letters.
[13] H. Coley,et al. Overcoming multidrug resistance in cancer: an update on the clinical strategy of inhibiting p-glycoprotein. , 2003, Cancer control : journal of the Moffitt Cancer Center.
[14] Xiujun Li,et al. Microfluidic selection and retention of a single cardiac myocyte, on-chip dye loading, cell contraction by chemical stimulation, and quantitative fluorescent analysis of intracellular calcium. , 2005, Analytical chemistry.
[15] Bin Wang,et al. Co-loading of photothermal agents and anticancer drugs into porous silicon nanoparticles with enhanced chemo-photothermal therapeutic efficacy to kill multidrug-resistant cancer cells. , 2018, Colloids and surfaces. B, Biointerfaces.
[16] K. Kohno,et al. A human canalicular multispecific organic anion transporter (cMOAT) gene is overexpressed in cisplatin-resistant human cancer cell lines with decreased drug accumulation. , 1996, Cancer research.
[17] M. Khoshayand,et al. Dual drug delivery system of PLGA nanoparticles to reverse drug resistance by altering BAX/Bcl-2 , 2018, Journal of Drug Delivery Science and Technology.
[18] Feng Shen,et al. Study of flow behaviors on single-cell manipulation and shear stress reduction in microfluidic chips using computational fluid dynamics simulations. , 2014, Biomicrofluidics.
[19] J. O'Brien,et al. Combining cyclosporin with chemotherapy controls intraocular retinoblastoma without requiring radiation. , 1996, Clinical cancer research : an official journal of the American Association for Cancer Research.
[20] Myung Soo Kim,et al. Development of exosome-encapsulated paclitaxel to overcome MDR in cancer cells. , 2016, Nanomedicine : nanotechnology, biology, and medicine.
[21] Richard M Maceiczyk,et al. Small but Perfectly Formed? Successes, Challenges, and Opportunities for Microfluidics in the Chemical and Biological Sciences , 2017 .
[22] J. Dou,et al. Downregulation of gene MDR1 by shRNA to reverse multidrug-resistance of ovarian cancer A2780 cells. , 2012, Journal of cancer research and therapeutics.
[23] Helene Andersson-Svahn,et al. Overview of single-cell analyses: microdevices and applications. , 2010, Lab on a chip.
[24] F. Sharom. ABC multidrug transporters: structure, function and role in chemoresistance. , 2008, Pharmacogenomics.
[25] A. Benito,et al. A cytotoxic ribonuclease reduces the expression level of P-glycoprotein in multidrug-resistant cell lines , 2012, Investigational New Drugs.
[26] Paul C H Li,et al. A simple and fast microfluidic approach of same-single-cell analysis (SASCA) for the study of multidrug resistance modulation in cancer cells. , 2011, Lab on a chip.
[27] M. Gottesman,et al. Drug resistance: still a daunting challenge to the successful treatment of AML. , 2012, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.
[28] Lei Zhang,et al. Design, synthesis and antineoplastic activity of novel hybrids of podophyllotoxin and indirubin against human leukaemia cancer cells as multifunctional anti-MDR agents. , 2018, Bioorganic & medicinal chemistry letters.
[29] Elinore M Mercer,et al. Microfluidic sorting of mammalian cells by optical force switching , 2005, Nature Biotechnology.
[30] T. Fojo,et al. ABC Transporters: Involvement in Multidrug Resistance and Drug Disposition , 2014 .
[31] M. Gandhi,et al. Dielectrophoretic Microfluidic Chip Enables Single-Cell Measurements for Multidrug Resistance in Heterogeneous Acute Myeloid Leukemia Patient Samples. , 2016, Analytical chemistry.
[32] A. Tsatsakis,et al. Resveratrol as MDR reversion molecule in breast cancer: An overview. , 2017, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.
[33] T. Kroll,et al. Monitoring the response of circulating epithelial tumor cells to adjuvant chemotherapy in breast cancer allows detection of patients at risk of early relapse. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[34] Xiujun Li,et al. Real‐time monitoring of intracellular calcium dynamic mobilization of a single cardiomyocyte in a microfluidic chip pertaining to drug discovery , 2007, Electrophoresis.
[35] Zhe-Sheng Chen,et al. Suppression of ABCG2 mediated MDR in vitro and in vivo by a novel inhibitor of ABCG2 drug transport , 2017, Pharmacological research.
[36] S. Cole,et al. Characterization of vincristine transport by the M(r) 190,000 multidrug resistance protein (MRP): evidence for cotransport with reduced glutathione. , 1998, Cancer research.
[37] E. Wang,et al. In vitro flow cytometry method to quantitatively assess inhibitors of P-glycoprotein. , 2000, Drug metabolism and disposition: the biological fate of chemicals.
[38] B. Hirst,et al. The ABCs of drug transport in intestine and liver: efflux proteins limiting drug absorption and bioavailability. , 2004, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[39] R. Jonker,et al. Effect of cyclosporin A on daunorubicin accumulation in multidrug-resistant P388 leukemia cells measured by real-time flow cytometry , 2004, Cancer Chemotherapy and Pharmacology.
[40] C. Higgins,et al. Multiple molecular mechanisms for multidrug resistance transporters , 2007, Nature.
[41] Paul C H Li,et al. Same-single-cell analysis using the microfluidic biochip to reveal drug accumulation enhancement by an amphiphilic diblock copolymer drug formulation , 2014, Analytical and Bioanalytical Chemistry.